SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to a significant European distribution partnership for its Anktiva cancer therapy, a critical FDA resubmission, and strong indications of major funding from Saudi Arabia. Investors are keenly watching for a potential short squeeze, fueled by enthusiasm for the drug's global market potential and ongoing discussions around US regulatory progress.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending following a significant stock drop sparked by its Q4 earnings, which revealed a net loss and weak guidance, intensifying community debate over the 'Buy Now, Pay Later' model's sustainability and the company's valuation after its already steep post-IPO decline.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is actively trending as its 'move-to-earn' model sparks ongoing debate within the crypto community. Many holders express optimism for a future rebound and are accumulating tokens despite a currently low valuation, while others remain skeptical of its long-term viability.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending after its NHS-Galleri cancer screening trial delivered mixed results, missing a primary endpoint but demonstrating promising early detection for several deadly cancers. The community is sharply divided, with some viewing the significant stock drop as an overreaction given the company's strong cash position and ongoing US FDA progress, while others see it as a justified response to the trial's outcome.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending following its robust earnings report which was subsequently overshadowed by conservative 2026 gold production guidance and higher anticipated costs. This has sparked a sharp debate among investors, with some seeing a compelling buying opportunity while others express concern about future profitability despite strong gold prices.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed after pricing a public stock offering at $5.45 and securing a royalty funding agreement, prompting a polarized community debate between significant dilution concerns and the strategic cash infusion to advance its promising prostate cancer BLA and broader oncology pipeline. The capital raises, including validation from RTW Investments, are viewed by some as crucial for accelerating regulatory milestones, while others express disappointment over the timing and share issuance.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

The cryptocurrency $SATOSHI is trending as the community fervently champions its tokenization of Satoshi Nakamoto, viewing it as the ultimate, timeless narrative and foundational identity of the entire crypto industry. Supporters believe its limited supply and unparalleled significance position it as a monumental asset destined to eclipse other major tokens, representing a unique opportunity akin to being early on Bitcoin.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to an S-1 filing for a Grayscale Trust and its deepening integration into the AI sector through NVIDIA's program, with the community highly engaged in discussions around its chain abstraction technology for seamless cross-chain interoperability and long-term potential.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing significant momentum following recent multi-million dollar contract wins from the U.S. Navy for P-8A Poseidon aircraft and a commercial robotics customer, solidifying its position in high-performance Edge AI for defense and industrial applications. The community is actively discussing its tight float, potential for a short squeeze, and substantial upside as a pure-play in the rapidly growing Edge AI sector, with expectations of larger military contracts on the horizon.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as the community eagerly awaits its Investor Day on February 23rd, expecting new data and strategic updates to confirm its 'best in class' drug potential. This anticipated catalyst, coupled with recent significant institutional re-accumulation and strong buyout speculation, fuels widespread belief that the stock is currently undervalued and on the brink of a substantial re-rating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVIDIA Falls on Data Center Misses: Buy the Dip with ETFs?

NVDA's Q2 beat was marred by a data center revenue miss, but ETFs like SMH and SHOC could help investors play its AI-driven growth, with lesser risks.

OpenAI raises $8.3 billion at $300 billion valuation, exceeding target - NYT

Investing.com -- OpenAI has secured $8.3 billion in funding at a $300 billion valuation, exceeding its target and completing the fundraising months ahead of schedule, according to the  New York Times  (NYSE:NYT) DealBook Newsletter.

U.S. tech names no longer behaving as a "homogeneous block," BCA Research says

Investing.com - A recent rally in tech stocks is becoming increasingly polarized, with names like Nvidia (NASDAQ:NVDA) and Microsoft (NASDAQ:MSFT) outpacing even its "Magnificent Seven" mega-cap peers such as Apple (NASDAQ:AAPL), according to analysts at BCA Research.

Nvidia orders 300,000 H20 chips as China demand surges, Reuters reports

Investing.com-- Nvidia (NASDAQ:NVDA) has placed fresh orders for 300,000 of its H20 AI chips with contract manufacturer Taiwan Semiconductor Manufacturing Co (TSMC) (TW:2330) amid rising demand from China, Reuters reported on Tuesday, citing unnamed sources.

Nvidia’s H20 stockpile won’t meet accelerating China demand: Jefferies

Investing.com -- Nvidia’s inventory of H20 AI chips is unlikely to satisfy surging demand in China following a temporary lift of U.S. export restrictions, according to Jefferies.

Trump’s ’big beautiful bill’ to boost big tech’s cash bonanza, AI dominance: MS

Investing.com -- President Trump’s One Big Beautiful Bill may be pitched as a game-changer for America’s future, but Morgan Stanley analysts believe the real impact is a windfall for Big Tech—delivering a powerful, cash-rich boost to the biggest names in AI, helping them dominate the future of AI. 

Morgan Stanley identifies next wave of AI-linked "alpha"

Investing.com - "Clear signs" of above-benchmark returns are emerging in companies whose operations are significantly reliant on artificial intelligence, according to analysts at Morgan Stanley.

Trump said he considered breaking up Nvidia; signs 3 orders to support AI

Investing.com-- U.S. President Donald Trump said on Wednesday that he had considered breaking up NVIDIA Corporation (NASDAQ:NVDA) to boost competition in the artificial intelligence sector, but had reconsidered over the difficulty of such a move.

Nvidia faces production hurdles in China H20 restart- The Information

Investing.com-- NVIDIA Corporation (NASDAQ:NVDA) told its Chinese customers that it has limited supplies of the H20 chip, the most powerful artificial intelligence chip it is allowed to sell in the country, The Information reported on Saturday. 

NVDL
GraniteShares 2x Long NVDA Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Latest NVDL News

NVDLGraniteShares 2x Long NVDA Daily ETF